Solid Biosciences Inc. SEC filings SLDB

Solid Biosciences Inc. has 737 filings in SEC EDGAR's recent list, going back to Aug 4, 2017. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (other events). The company's fiscal year ends on December 31.

Solid Biosciences Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
4 Insider transaction Oct 26, 2026 Oct 1, 2026
4 Insider transaction Oct 20, 2026 Oct 18, 2026
4 Insider transaction Oct 6, 2026 Oct 2, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
8-K Current report
Other events
Aug 6, 2026 Aug 6, 2026
424B5 Prospectus supplement Aug 6, 2026 —
S-3ASR Automatic shelf registration Aug 6, 2026 —
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
SCHEDULE 13G Ownership over 5% (passive) Aug 6, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jul 30, 2026 —
4 Insider transaction Jul 7, 2026 Jul 2, 2026
3 Initial insider ownership Jun 24, 2026 Jun 22, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Jun 24, 2026 —
4 Insider transaction Jun 11, 2026 Jun 10, 2026
4 Insider transaction Jun 11, 2026 Jun 10, 2026
4 Insider transaction Jun 11, 2026 Jun 10, 2026
4 Insider transaction Jun 11, 2026 Jun 10, 2026
4 Insider transaction Jun 11, 2026 Jun 10, 2026
4 Insider transaction Jun 11, 2026 Jun 10, 2026
4 Insider transaction Jun 11, 2026 Jun 10, 2026
4 Insider transaction Jun 11, 2026 Jun 10, 2026
4 Insider transaction Jun 11, 2026 Jun 10, 2026
8-K Current report
Shareholder vote results
Jun 10, 2026 Jun 10, 2026
424B7 Filing Jun 5, 2026 —
10-Q Quarterly report May 12, 2026 Mar 31, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 5, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 27, 2026 —
ARS Annual report to shareholders Apr 23, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 23, 2026 —
DEF 14A Proxy statement Apr 23, 2026 Jun 10, 2026
4 Insider transaction Apr 21, 2026 Jan 29, 2026
4 Insider transaction Apr 21, 2026 Jan 29, 2026
4 Insider transaction Apr 21, 2026 Jan 29, 2026
4 Insider transaction Apr 21, 2026 Jan 29, 2026
4 Insider transaction Apr 21, 2026 Jan 29, 2026
4 Insider transaction Apr 21, 2026 Jan 29, 2026
PRE 14A Preliminary proxy statement Apr 10, 2026 Jun 10, 2026
8-K Current report
Officer or director change
Apr 10, 2026 Apr 10, 2026
4 Insider transaction Apr 2, 2026 Apr 2, 2026
EFFECT Filing Mar 31, 2026 —
EFFECT Filing Mar 31, 2026 —
CORRESP Letter to the SEC Mar 27, 2026 —
CORRESP Letter to the SEC Mar 27, 2026 —
UPLOAD Letter from the SEC Mar 24, 2026 —
UPLOAD Letter from the SEC Mar 24, 2026 —
S-3 Shelf registration Mar 19, 2026 —
S-3 Shelf registration Mar 19, 2026 —
S-8 Employee stock plan registration Mar 19, 2026 —
10-K Annual report Mar 19, 2026 Dec 31, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 17, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Mar 12, 2026 Mar 11, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 11, 2026 —
4 Insider transaction Mar 11, 2026 Mar 9, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 10, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 10, 2026 —
8-K Current report
Material agreement, Results of operations, Unregistered share sale, Other events
Mar 6, 2026 Mar 6, 2026
4 Insider transaction Feb 18, 2026 Feb 13, 2026
144 Notice of proposed sale Feb 18, 2026 —
144 Notice of proposed sale Feb 18, 2026 —
4 Insider transaction Feb 18, 2026 Feb 13, 2026
144 Notice of proposed sale Feb 18, 2026 —
4 Insider transaction Feb 18, 2026 Feb 13, 2026
144 Notice of proposed sale Feb 18, 2026 —
144 Notice of proposed sale Feb 18, 2026 —
4 Insider transaction Feb 18, 2026 Feb 13, 2026
4 Insider transaction Feb 18, 2026 Feb 13, 2026
144 Notice of proposed sale Feb 18, 2026 —
4 Insider transaction Feb 18, 2026 Feb 13, 2026
144 Notice of proposed sale Feb 18, 2026 —
4 Insider transaction Feb 18, 2026 Feb 13, 2026
SCHEDULE 13G Ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2026 —
4 Insider transaction Feb 6, 2026 Feb 4, 2026
4 Insider transaction Feb 6, 2026 Feb 4, 2026
4 Insider transaction Feb 6, 2026 Feb 4, 2026
4 Insider transaction Feb 6, 2026 Feb 4, 2026
4 Insider transaction Feb 6, 2026 Feb 4, 2026
4 Insider transaction Feb 6, 2026 Feb 4, 2026
4 Insider transaction Feb 6, 2026 Feb 4, 2026
144 Notice of proposed sale Feb 4, 2026 —
144 Notice of proposed sale Feb 4, 2026 —
144 Notice of proposed sale Feb 4, 2026 —
144 Notice of proposed sale Feb 4, 2026 —
144 Notice of proposed sale Feb 4, 2026 —
144 Notice of proposed sale Feb 4, 2026 —
144 Notice of proposed sale Feb 4, 2026 —
4 Insider transaction Feb 2, 2026 Jan 29, 2026
4 Insider transaction Feb 2, 2026 Jan 29, 2026
4 Insider transaction Feb 2, 2026 Jan 29, 2026
4 Insider transaction Feb 2, 2026 Jan 29, 2026
4 Insider transaction Feb 2, 2026 Jan 29, 2026
4 Insider transaction Feb 2, 2026 Jan 29, 2026
4 Insider transaction Feb 2, 2026 Jan 27, 2026
144 Notice of proposed sale Feb 2, 2026 —
144 Notice of proposed sale Feb 2, 2026 —
144 Notice of proposed sale Feb 2, 2026 —
144 Notice of proposed sale Feb 2, 2026 —
144 Notice of proposed sale Feb 2, 2026 —
144 Notice of proposed sale Feb 2, 2026 —
4 Insider transaction Jan 30, 2026 Jan 27, 2026
4 Insider transaction Jan 13, 2026 Jan 9, 2026
144 Notice of proposed sale Jan 13, 2026 —
4 Insider transaction Jan 7, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 3, 2026
4 Insider transaction Dec 4, 2025 Dec 2, 2025
4 Insider transaction Dec 4, 2025 Dec 2, 2025
4 Insider transaction Dec 4, 2025 Dec 2, 2025
4 Insider transaction Dec 4, 2025 Dec 2, 2025
144 Notice of proposed sale Dec 3, 2025 —
4 Insider transaction Nov 13, 2025 Nov 10, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 13, 2025 —
10-Q Quarterly report Nov 3, 2025 Sep 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Nov 3, 2025 Nov 3, 2025
4 Insider transaction Oct 21, 2025 Oct 18, 2025
4 Insider transaction Oct 7, 2025 Oct 6, 2025
4 Insider transaction Aug 18, 2025 Aug 14, 2025
4 Insider transaction Aug 18, 2025 Aug 14, 2025
4 Insider transaction Aug 18, 2025 Aug 14, 2025
4 Insider transaction Aug 18, 2025 Aug 14, 2025
4 Insider transaction Aug 18, 2025 Aug 14, 2025
4 Insider transaction Aug 18, 2025 Aug 14, 2025
4 Insider transaction Aug 18, 2025 Aug 14, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
SCHEDULE 13G Ownership over 5% (passive) Jul 17, 2025 —
4 Insider transaction Jul 8, 2025 Jul 6, 2025
4 Insider transaction Jun 18, 2025 Jun 12, 2025
4 Insider transaction Jun 13, 2025 Jun 12, 2025
4 Insider transaction Jun 13, 2025 Jun 12, 2025
4 Insider transaction Jun 13, 2025 Jun 12, 2025
4 Insider transaction Jun 13, 2025 Jun 12, 2025
4 Insider transaction Jun 13, 2025 Jun 12, 2025
4 Insider transaction Jun 13, 2025 Jun 12, 2025
4 Insider transaction Jun 13, 2025 Jun 12, 2025
4 Insider transaction Jun 13, 2025 Jun 12, 2025
8-K Current report
Officer or director change, Shareholder vote results
Jun 13, 2025 Jun 12, 2025
S-8 Employee stock plan registration Jun 13, 2025 —
EFFECT Filing May 27, 2025 —
CORRESP Letter to the SEC May 22, 2025 —
UPLOAD Letter from the SEC May 21, 2025 —
8-K Current report
Other events
May 15, 2025 May 15, 2025
424B5 Prospectus supplement May 15, 2025 —
S-3 Shelf registration May 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
10-Q Quarterly report May 15, 2025 Mar 31, 2025
SCHEDULE 13G Ownership over 5% (passive) May 12, 2025 —
ARS Annual report to shareholders Apr 25, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 25, 2025 —
DEF 14A Proxy statement Apr 25, 2025 Jun 12, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 17, 2025 —
PRE 14A Preliminary proxy statement Apr 11, 2025 Jun 12, 2025
4 Insider transaction Apr 8, 2025 Apr 6, 2025
EFFECT Filing Mar 14, 2025 —
EFFECT Filing Mar 14, 2025 —
4 Insider transaction Mar 13, 2025 Mar 11, 2025
CORRESP Letter to the SEC Mar 12, 2025 —
CORRESP Letter to the SEC Mar 12, 2025 —
UPLOAD Letter from the SEC Mar 11, 2025 —
UPLOAD Letter from the SEC Mar 11, 2025 —
S-3 Shelf registration Mar 6, 2025 —
S-3 Shelf registration Mar 6, 2025 —
S-8 Employee stock plan registration Mar 6, 2025 —
10-K Annual report Mar 6, 2025 Dec 31, 2024
SCHEDULE 13G Ownership over 5% (passive) Feb 25, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Feb 21, 2025 —
4 Insider transaction Feb 21, 2025 Feb 19, 2025
4 Insider transaction Feb 21, 2025 Feb 19, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Feb 21, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Feb 21, 2025 —
4 Insider transaction Feb 21, 2025 Feb 19, 2025
4 Insider transaction Feb 19, 2025 Feb 18, 2025
3 Initial insider ownership Feb 19, 2025 Feb 18, 2025
8-K Current report
Material agreement, Other events
Feb 18, 2025 Feb 18, 2025
424B5 Prospectus supplement Feb 18, 2025 —
FWP Free writing prospectus Feb 18, 2025 —
4 Insider transaction Feb 18, 2025 Feb 13, 2025
4 Insider transaction Feb 18, 2025 Feb 13, 2025
4 Insider transaction Feb 18, 2025 Feb 13, 2025
4 Insider transaction Feb 18, 2025 Feb 13, 2025
4 Insider transaction Feb 18, 2025 Feb 13, 2025
4 Insider transaction Feb 18, 2025 Feb 13, 2025
4 Insider transaction Feb 18, 2025 Feb 13, 2025
8-K Current report
Other events
Feb 18, 2025 Feb 18, 2025
8-K Current report
Results of operations, Other events
Feb 18, 2025 Feb 18, 2025
144 Notice of proposed sale Feb 14, 2025 —
144 Notice of proposed sale Feb 14, 2025 —
144 Notice of proposed sale Feb 14, 2025 —
144 Notice of proposed sale Feb 14, 2025 —
144 Notice of proposed sale Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2025 —
4 Insider transaction Feb 11, 2025 Jan 31, 2025
4 Insider transaction Feb 11, 2025 Jan 31, 2025
4 Insider transaction Feb 11, 2025 Jan 31, 2025
4 Insider transaction Feb 11, 2025 Jan 31, 2025
4 Insider transaction Feb 11, 2025 Jan 31, 2025
4 Insider transaction Feb 11, 2025 Jan 31, 2025

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
SLDB (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Charlestown, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1707502
Former names
Solid Biosciences, LLC (until Jan 25, 2018)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.